Henrik Morville Schrøder

Henrik Morville Schrøder

Auto-generated profile, based on publicly available information

Henrik Morville Schrøder

Department of Orthopaedic Surgery, Næstved Hospital, Næstved, Denmark

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2021 in European journal of pain
Verified
Journal Article
Open access
PDF file
PHPætur M. Holm
Pætur M. Holm
KPKristian Kjær Petersen
Kristian Kjær Petersen
MWMathias Wernbom
Mathias Wernbom
HSHenrik Morville Schrøder
Henrik Morville Schrøder
LALars Arendt-Nielsen
Lars Arendt-Nielsen
SSSøren T Skou
Søren T Skou
Background: There is a lack of evidence of the relative effects of different exercise modes on pain sensitization and pain intensity in individuals with knee osteoarthritis (KOA).Methods: Ninety individuals with radiographic and symptomatic KOA, ineligible for knee replacement surgery, were randomized to 12 weeks of twice‐weekly strength training in addition to neuromuscular exercise and education (ST+NEMEX‐EDU) or neuromuscular exercise and education alone (NEMEX‐EDU). Outcomes were bilateral, lower‐leg, cuff pressure pain‐ and tolerance thresholds (PPT, PTT), temporal summation (TS), conditioned pain modulation (CPM), self‐reported knee pain intensity and number of painful body sites.Results: After 12 weeks of exercise, we found significant differences in increases in PPT (−5.01 kPa (−8.29 to −1.73, p = .0028)) and PTT (−8.02 kPa (−12.22 to −3.82, p = .0002)) in the KOA leg in favour of ST+NEMEX‐EDU. We found no difference in effects between groups on TS, CPM or number of painful body sites. In contrast, there were significantly greater pain‐relieving effects on VAS mean knee pain during the last week (−8.4 mm (−16.2 to −0.5, p = .0364) and during function (−16.0 mm (−24.8 to −7.3, p = .0004)) in favour of NEMEX‐EDU after 12 weeks of exercise.Conclusion: Additional strength training reduced pain sensitization compared to neuromuscular exercise and education alone, but also attenuated the reduction in pain intensity compared to neuromuscular exercise and education alone. The study provides the first dose‐ and type‐specific insight into the effects of a sustained exercise period on pain sensitization in KOA. Future studies are needed to elucidate the role of different exercise modes.Significance: This study is an important step towards better understanding the effects of exercise in pain management of chronic musculoskeletal conditions. We found that strength training in addition to neuromuscular exercise and education compared with neuromuscular exercise and education only had a differential impact on pain sensitization and pain intensity, but also that regardless of the exercise mode, the positive effects on pain sensitization and pain intensity were comparable to the effects of other therapeutic interventions for individuals with knee osteoarthritis.

4 December 2019 in Acta Orthopaedica
Verified
Journal Article
Open access
VVVeronique Vestergaard
Veronique Vestergaard
APAlma Becic Pedersen
Alma Becic Pedersen
PTPeter Toft Tengberg
Peter Toft Tengberg
ATAnders Troelsen
Anders Troelsen
HSHenrik Morville Schrøder
Henrik Morville Schrøder
Background and purpose — Knee fracture treatment burden remains unknown, impeding proper use of hospital resources. We examined 20-year trends in incidence rates (IRs) and patient-, fracture-, and treatment-related characteristics of knee fracture patients. Patients and methods — This nationwide cohort study of prospectively collected data including patients with distal femoral, patellar, and proximal tibial fractures from the Danish National Patient Registry during 1998–2017, assesses IRs of knee fractures (per 105 inhabitants) as well as patient-, fracture-, and treatment-related characteristics of knee fracture patients. Results — During 1998–2017, 60,823 patients (median age 55; 57% female) sustained 74,106 knee fractures. 74% of the study population had a Charlson Comorbidity Index (CCI) of 0 and 18% a CCI of ≥ 2. 51% were proximal tibial fractures, 31% patellar fractures, and 18% distal femoral fractures. At the time of knee fracture, 20% patients had concomitant near-knee fractures (femur/tibia/fibula shaft/hip/ankle), 13% concomitant fractures (pelvic/spine/thorax/upper extremities), 5% osteoporosis, and 4% primary knee osteoarthritis. Over 1/3 knee fractures were surgically treated and of these 86% were open-reduction internal fixations, 9% external fixations, and 5% knee arthroplasties. The most common surgery type was proximal tibia plating (n = 4,868; 60% female). Knee fracture IR increased 12% to 70, females aged > 51 had the highest knee fracture IR, proximal tibial fracture had the highest knee fracture type IR (32) and surgically treated knee fracture IR increased 35% to 23. Interpretation — Knee fracture IRs, especially of surgically treated knee fractures, are increasing and proximal tibial fracture has the highest knee fracture type IR. Females aged > 51 and patients with comorbidity are associated with knee fracture, proximal tibial fracture, proximal tibial fracture surgery, and posttraumatic knee arthroplasty.

1 December 2012 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
CJClaus L. Jensen
Claus L. Jensen
Michael Mørk PetersenMichael Mørk Petersen
Michael Mørk Petersen
HSHenrik M. Schrøder
Henrik M. Schrøder
GFGunnar Flivik
Gunnar Flivik
BLBjarne Lund
Bjarne Lund

27 September 2023 in Osteoarthritis and Cartilage Open
Verified
Journal Article
Open access
SBSimon Majormoen Bruhn
Simon Majormoen Bruhn
SSSøren T Skou
Søren T Skou
LHLasse Kindler Harris
Lasse Kindler Harris
TBThomas Bandholm
Thomas Bandholm
AMAnne Møller
Anne Møller
LILina Holm Ingelsrud
Lina Holm Ingelsrud
To describe 1) the proportion of patients with knee osteoarthritis (OA) undergoing guideline-adherent core treatments until six months after primary referral to an orthopaedic surgeon, 2) which specific treatment pathways these patients undertake and 3) the characteristics of patients choosing different treatment pathways. This prospective cohort study consecutively invited patients referred to an orthopaedic surgeon due to knee OA at two Danish hospitals from October 2018 to December 2020. Before and six months after consulting the surgeon, patients answered a questionnaire reporting which treatments they had received for knee OA. The proportion receiving the combination of guideline-adherent treatments (i.e., exercise, education, and dietary weight management if needed) was determined. We evaluated the specific treatment usage before and until six months after the consultation and investigated characteristics of patients undertaking different pathways. Out of 5251 eligible patients, 2574 (49%) had complete data and were included in analyses. 23% received guideline-adherent treatments, 10% had no treatment. Patients underwent 1143 unique treatment pathways, 62% including treatments not recommended/recommended against. Those who underwent guideline-adherent pathways had similar characteristics to those who did not but tended to be females, retired, had longer-lasting knee problems, have comorbidities, and higher education levels. Only one in four patients with knee OA received treatment adhering to clinical guidelines before and six months after consulting the surgeon. Patients used many different treatment pathways. There is a need for a structured effort to increase the use of guideline-adherent core treatments. Registration: NCT03746184, Protocol: PMID: 34233992.

9 February 2026 in Journal of Bone and Joint Surgery
Verified
Journal Article
Open access
JMJacob Fyhring Mortensen
Jacob Fyhring Mortensen
PBPaul Blanche
Paul Blanche
CBClaes Sjørslev Blom
Claes Sjørslev Blom
MVMorten Vase
Morten Vase
SOSøren Overgaard
Søren Overgaard
AOAnders Odgaard
Anders Odgaard
Background: The superiority of medial unicompartmental knee arthroplasty (mUKA) versus total knee arthroplasty (TKA) for isolated anteromedial knee osteoarthritis (AMOA) remains a subject of ongoing debate. We present the 2-year results of a multicenter, randomized trial comparing the patient-reported and clinical outcomes of these 2 implant types in the treatment of AMOA. Methods: This double-blinded superiority trial recruited patients with severe AMOA at 10 arthroplasty centers and randomized them to undergo either mUKA or TKA. The primary outcome was the average improvement in the Oxford Knee Score (OKS) over 2 years, analyzed by intention-to-treat. A range of patient-reported outcomes served as secondary outcomes. Death, revision, and other reoperations were analyzed as serious adverse events (SAEs). Results: Between September 2017 and March 2021, 350 patients were randomized: 177 (79 female, 98 male; mean age, 67.7 ± 7.5 years) to mUKA and 173 (84 female, 89 male; mean age, 66.7 ± 7.8 years) to TKA. The average 2-year OKS improvement differed by 3.5 points (95% CI, 2.3 to 4.7; p < 0.001) in favor of mUKA, although this difference was below the generally accepted minimal clinically important difference (MCID) of 4 to 5 points. Ten of the 12 secondary outcomes favored mUKA, while the remaining 2 were nonsignificant. The differences in the Forgotten Joint Score (FJS) (14.1; 95% CI, 9.5 to 18.6), range of motion during the first 2 years (7.0°; 95% CI, 5.3° to 8.7°) and at 2 years (5.5°; 95% CI, 3.6° to 7.4°), Knee injury and Osteoarthritis Outcome Score (KOOS) symptoms score (10.3; 95% CI, 7.8 to 12.8), and Short Form-36 (SF-36) bodily pain score (7.6; 95% CI, 4.1 to 11.1) all favored mUKA and reached the MCID. Non-revision reoperations were performed in 4 patients (2.3%) after mUKA and in 12 patients (6.9%) after TKA (9 of the 12 underwent manipulation under anesthesia); the difference was 4.7% (95% CI, 0.2% to 9.8%). There were no differences in the rates of revision or death between the groups. Conclusions: Averaged over the 2-year follow-up, mUKA demonstrated minor advantages that did not achieve clear clinical superiority on the basis of the OKS difference. However, the FJS, range of motion, KOOS symptoms score, and SF-36 bodily pain score all demonstrated differences in favor of mUKA that were clinically meaningful. The overall findings suggest that mUKA and TKA yield similarly favorable short-term results, with small advantages for mUKA. Level of Evidence: Therapeutic Level I . See Instructions for Authors for a complete description of levels of evidence.